Skip to main content

MARSHALL WACE, LLP

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1318757 LONDON, X0

Position in IOVA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,268,196
+$8,076,932 QoQ
Shares Held
2,355,612
+2018.4% QoQ
Ownership
0.528%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in IOVA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. IOVA ranks #69 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IOVA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,268,196 2,355,612
2025-06-30 $191,264 111,200
2025-03-31 $132,007 39,642
2024-12-31 $8,365,367 1,130,455
2024-06-30 $12,928,681 1,612,055
2023-09-30 $159,300 35,011
2022-12-31 $2,360,868 369,463
2022-03-31 $848,367 50,953
2021-12-31 $16,439,544 861,160
2021-03-31 $1,323,356 41,799
2020-09-30 $1,910,215 58,026
2020-06-30 $751,882 27,391